Syra Health Corp (SYRA) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Syra Health Corp (SYRA) stock forecast summary
On Oct. 16, 2026, SYRA is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5184 stocks scored that day.
Syra Health Corp is a small-cap company with a market capitalization of $15M.
For SYRA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 71.0%, measured on 289 forecast dates between 2023-11-17 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 35.0%, measured on 332 forecast dates between 2023-11-17 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SYRA included.
Follow SYRA freeSYRA price chart and AI forecast
How SYRA ranks among 5184 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Syra Health Corp (SYRA) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Employment Agencies peers listed below that report each metric.
Valuation & Market
| Metric | SYRA | Rank |
|---|---|---|
| Market Cap | $15M | – |
| P/B Ratio | 5.65x | – |
| EPS | $-0.05 | – |
| Book Value/Share | $0.15 | – |
| Revenue/Share | $0.47 | – |
Profitability & Margins
| Metric | SYRA | Rank |
|---|---|---|
| ROE | 23.0% | – |
| ROA | 15.8% | – |
| ROIC | 2.8% | – |
| Gross Margin | 36.2% | – |
| Operating Margin | 0.8% | – |
| Net Margin | 6.9% | – |
| EBT Margin | 0.8% | – |
Financial Health
| Metric | SYRA | Rank |
|---|---|---|
| Current Ratio | 3.13x | – |
| D/E Ratio | 0.45x | – |
| Financial Leverage | 1.45x | – |
| Interest Coverage | 113.5x | – |
| Working Capital | $3M | – |
Cash Flow
| Metric | SYRA | Rank |
|---|---|---|
| Operating Cash Flow | $110K | – |
Operational Efficiency
| Metric | SYRA | Rank |
|---|---|---|
| Asset Turnover | 2.11x | – |
| Receivables Turnover | 5.5x | – |
| Fixed Assets Turnover | 1558.2x | – |
| Days Sales Outstanding | 66 days | – |
Income Statement
| Metric | SYRA | Rank |
|---|---|---|
| Total Revenue | $8M | – |
| Operating Income | $70K | – |
| Net Income | $610K | – |
| R&D Expense | $60K | – |
| SG&A Expense | $940K | – |
| Cost of Goods Sold | $5M | – |
Dividend & Shareholder Information
| Metric | SYRA | Rank |
|---|---|---|
| Shares Outstanding | 17M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $4M | 97.9% of assets |
| Cash & Short-term Investments | $2M | 55.3% of assets |
| Accounts Receivable | $1M | 38.4% of assets |
| Total Liabilities | $1M | 31.3% of assets |
SYRA quarterly financials and insider trading
Syra Health Corp (SYRA) industry peers
Companies classified under the same SEC industry code as Syra Health Corp (Services-Employment Agencies): 3 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere SYRA sits on the market map
Syra Health Corp (SYRA) stock news
Loading...
Syra Health Corp (SYRA) stock forecast FAQ
What is the Syra Health Corp (SYRA) stock forecast?
On Oct. 16, 2026, SYRA is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5184 stocks scored that day.
How accurate are Syra Health Corp stock predictions?
For SYRA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 71.0%, measured on 289 forecast dates between 2023-11-17 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 35.0%, measured on 332 forecast dates between 2023-11-17 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Syra Health Corp forecasts updated?
Syra Health Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Syra Health Corp's industry peers?
3 issuers in our coverage, SYRA included, share the SEC industry code Services-Employment Agencies. The largest are: Korn Ferry (KFY), Gee Group Inc. (JOB).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.